Skip Navigation

Vaccine Safety Bibliography - August 2013

1. Continuing Medical Education: U.S. Hospitalizations for Pneumonia after a Decade of Pneumococcal Vaccination. N Engl J Med. 2013 Jul 18. [Epub ahead of print].

2. Dire necessity and transformation: entry-points for modern science in Islamic  bioethical assessment of .orcine products in vaccines. Br Dent J. 2013 Jul 26; 215(2):75.

3. Human papillomavirus vaccination coverage among adolescent girls, 2007-2012, and postlicensure vaccine safety monitoring, 2006-2013 - United States. MMWR Morb Mortal Wkly Rep. 2013 Jul 26; 62(29):591-5.

4. NewsCap: Vaccines don't cause Guillain-Barré Syndrome (GBS). Am J Nurs. 2013 Jul; 113(7):14.

5. Pneumococcal vaccination programme followed by sustained declines in all cause pneumonia. BMJ. 2013 Jul 17; 347:f4526.

6. Recommended immunization schedule for children and adolescents in Korea, the Korean Pediatric Society, 2013 (The Committee on Infectious Diseases, the Korean  Pediatric Society). Clin Exp Vaccine Res. 2013 Jul; 2(2):144-7.

7. Ahmed T, Bhuiyan TR, Zaman K, Sinclair D, Qadri F. Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea. Cochrane Database Syst Rev. 2013 Jul 5; 7:CD009029. [Epub ahead of print].

8. An Y, Rininger JA, Jarvis DL, Jing X, Ye Z, Aumiller JJ, Eichelberger M, Cipollo JF. Comparative Glycomics Analysis of Influenza Hemagglutinin (H5N1) Produced in Vaccine Relevant Cell Platforms. J Proteome Res. 2013 Jul 24. [Epub ahead of print].

9. Andrus JK, Walker DG. Evidence base for new vaccine introduction in Latin America and the Caribbean. Vaccine. 2013 Jul 2; 31 Suppl 3:C2-3.

10. Andréasson S. Vaccine adjuvants: insights from industry. Expert Rev Vaccines. 2013 Jul; 12(7):731-2.

11. Arya SC, Agarwal N. Comment on: Vaccination for typhoid fever in Sub-Saharan  Africa:. Hum Vaccin Immunother. 2013 Jul 10; 9(11). [Epub ahead of print].

12. Assis AS, Valle DA, Antunes GR, Tibiriça SH, Assis RM, Leite JP, Carvalho IP, Rosa E Silva ML. Rotavirus epidemiology before and after vaccine introduction. J  Pediatr (Rio J). 2013 Jul 18. [Epub ahead of print].

13. Auranen K, Rinta-Kokko H, Goldblatt D, Nohynek H, O'Brien KL, Satzke C, Simell B, Tanskanen A, Käyhty H. Design questions for Streptococcus pneumonia vaccine trials with a colonisation endpoint. Vaccine. 2013 Jul 18. [Epub ahead of print].

14. Avelino-Silva VI, Leal FE, Sabino EC, Nishiya AS, da Silva Freire M, Blumm F, Rocha V, Rodrigues CA, Novis YS, Kallas EG. Yellow fever vaccine viremia following ablative BM suppression in AML. Bone Marrow Transplant. 2013 Jul; 48(7):1008-9.

15. Baldwin AS, Bruce CM, Tiro JA. Understanding how mothers of adolescent girls  obtain information about the human papillomavirus vaccine: Associations between mothers' health beliefs, information seeking, and vaccination intentions in an ethnically diverse sample. J Health Psychol. 2013 Jul; 18(7):926-38.

16. Bali NK, Ashraf M, Ahmad F, Khan UH, Widdowson MA, Lal RB, Koul PA. Knowledge, attitude, and practices about the seasonal influenza vaccination among healthcare workers in Srinagar, India. Influenza Other Respi Viruses. 2013 Jul; 7(4):540-5.

17. Baxter R, Bartlett J, Rowhani-Rahbar A, Fireman B, Klein NP. Effectiveness of pertussis vaccines for adolescents and adults: case-control study. BMJ. 2013 Jul 17;347:f4249.

18. Becker-Dreps S, Meléndez M, Liu L, Enrique Zambrana L, Paniagua M, Weber DJ,  Hudgens MG, Cáceres M, Källeståll C, Morgan DR, Espinoza F, Peña R. Community Diarrhea Incidence Before and After Rotavirus Vaccine Introduction in Nicaragua.  Am J Trop Med Hyg. 2013 Jul 1. [Epub ahead of print].

19. Berti F, Adamo R. Recent Mechanistic Insights on Glycoconjugate Vaccines and  Future Perspectives. ACS Chem Biol. 2013 Jul 23. [Epub ahead of print].

20. Beyazova U, Yüksel N, Aksakal FN, Camurdan AD. Comparison of the reactogenicity of three different immunization schedules including diphtheria, tetanus, pertussis, Haemophilus influenza b and polio vaccine in Turkey. Trans R  Soc Trop Med Hyg. 2013 Jul; 107(7):438-43.

21. Bhaumik S. New Rotavirus vaccine in India faces controversy. CMAJ. 2013 Jul 15. [Epub ahead of print].

22. Black S, Margarit I, Rappuoli R. Preventing newborn infection with maternal immunization. Sci Transl Med. 2013 Jul 24; 5(195):195ps11.

 23. Blanchard-Rohner G, Snape MD, Kelly DF, O'Connor D, John T, Kibwana E, Parks  H, Ford K, Dull PM, Pollard AJ. Seroprevalence and Placental Transmission of Maternal Antibodies Specific for Neisseria meningitidis Serogroups A, C, Y and W135 and Influence of Maternal Antibodies on the Immune Response to a Primary Course of MenACWY-CRM Vaccine in the United Kingdom. Pediatr Infect Dis J. 2013 Jul; 32(7):768-76.

 24. Blank NR, Caplan AL, Constable C. Exempting schoolchildren from immunizations: States with few barriers had highest rates of nonmedical exemptions. Health Aff (Millwood). 2013 Jul; 32(7):1282-90.

25. Blomberg M, Dehlendorff C, Munk C, Kjaer SK. Strongly Decreased Risk of Genital Warts After Vaccination Against Human Papillomavirus: Nationwide Follow-up of Vaccinated and Unvaccinated Girls in Denmark. Clin Infect Dis. 2013  Jul 15. [Epub ahead of print].

26. Bonanni P, Gershon A, Gershon M, Kulcsár A, Papaevangelou V, Rentier B, Sadzot-Delvaux C, Usonis V, Vesikari T, Weil-Olivier C, de Winter P, Wutzler P. Primary Versus Secondary Failure After Varicella Vaccination: Implications for Interval Between 2 Doses. Pediatr Infect Dis J. 2013 Jul; 32(7):e305-e313.

27. Bonduelle O, Yahia N, Siberil S, Benhabiles N, Carrat F, Krivine A, Rozenberg F, Dimitrov J, Kaveri SV, Curjol A, Tindel M, Louet M, Desert F, Launay O, Loulergue P, Badre G, Katlama C, Bricaire F, Samri A, Rousset D, van der Werf S,  Jauréguiberry S, Combadiere B. Longitudinal and integrative biomodeling of effector and memory immune compartments after inactivated influenza vaccination.  J Immunol. 2013 Jul 15; 191(2):623-31.

28. Botsis T, Woo EJ, Ball R. Application of information retrieval approaches to  case classification in the vaccine adverse event reporting system. Drug Saf. 2013 Jul; 36(7):573-82.

29. Bouaziz JD, Buanec HL, Zagury D, Bagot M, Bensussan A. [Update on the use of  active anti-cytokine therapies with ki.oid vaccines for the treatment of inflammatory diseases]. Med Sci (Paris). 2013 Jun Jul; 29(6-7):669-70.

30. Boyd CA, Gazmararian JA, Thompson WW. Knowledge, attitudes, and behaviors of  low-income women considered high priority for receiving the novel influenza A (H1N1) vaccine. Matern Child Health J. 2013 Jul; 17(5):852-61.

31. Breglio KJ, Rosh JR. Health maintenance and vaccination strategies in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2013 Jul; 19(8):1740-4.

32. Brito LA, Malyala P, O'Hagan DT. Vaccine adjuvant formulations: A pharmaceutical perspective. Semin Immunol. 2013 Jul 11. [Epub ahead of print].

33. Broutet N, Lehnertz N, Mehl G, Camacho AV, Bloem P, Chandra-Mouli V, Ferguson J, Dick B. Effective health interventions for adolescents that could be integrated with human papillomavirus vaccination programs. J Adolesc Health. 2013 Jul; 53(1):6-13.

34. Buttenheim AM, Cherng ST, Asch DA. Provider dismissal policies and clustering of vaccine-hesitant families: An agent-based modeling approach. Hum Vaccin Immunother. 2013 Jul 5;9(8). [Epub ahead of print].

35. Bärnighausen T, Bloom DE, Cafiero ET, O'Brien JC. Valuing the broader benefits of dengue vaccination, with a preliminary application to Brazil. Semin Immunol. 2013 Jul 22. [Epub ahead of print].

36. Böhmer MM, Hellenbrand W, Matysiak-Klose D, Heininger U, Müters S, Wichmann O. [Pertussis vaccination coverage among adults in Germany]. Dtsch Med Wochenschr. 2013 Jul; 138(28-29):1451-7.

37. Campos LM, Silva CA, Aikawa NE, Jesus AA, Moraes JC, Miraglia J, Ishida MA, Bueno C, Pereira RM, Bonfa E. High disease acivity: an independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2013 Jul; 65(7):1121-7.

38. Carrico RM, Wiemken T, Westhusing K, Christensen D, McKinney WP. Health care  personnel immunization programs: An assessment of knowledge and practice among infection preventionists in US health care facilities. Am J Infect Control. 2013 Jul;41(7):581-4.

39. Castañeda-Orjuela C, Romero M, Arce P, Resch S, Janusz CB, Toscano CM, De la  Hoz-Restrepo F. Using standardized tools to improve immunization costing data for program planning: The cost of the Colombian Expanded Program on Immunization. Vaccine. 2013 Jul 2; 31 Suppl 3:C72-9.

40. Castiglia P, Piana A, Sotgiu G. Is there an authentic increased risk of pneumococcal pneumonia among young mothers whose children were fully vaccinated with PCV7? The role of methodological shortcomings. Vaccine. 2013 Jul 18; 31(33):3361-2.

41. Castilla J, Godoy P, Domínguez A, Martínez-Baz I, Astray J, Martín V, Delgado-Rodríguez M, Baricot M, Soldevila N, Mayoral JM, Quintana JM, Galán JC, Castro A, González-Candelas F, Garín O, Saez M, Tamames S, Pumarola T; CIBERESP Cases and Controls in Influenza Working Group Spain. Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza. Clin Infect Dis. 2013 Jul; 57(2):167-75.

 42. Cerpa-Cruz S, Paredes-Casillas P, Landeros Navarro E, Bernard-Medina AG, Martínez-Bonilla G, Gutiérrez-Ureña S. Adverse events following immunization with vaccines containing adjuvants. Immunol Res. 2013 Jul;56(2-3):299-303.

43. Chen SY, Tsai CN, Chen CL, Chao SC, Lee YS, Lai MW, Chen CC, Huang WL, Chiu CH. Severe Viral Gastroenteritis in Children after Sub-optimal Rotavirus Immunization in Taiwan. Pediatr Infect Dis J. 2013 Jul 22. [Epub ahead of print].

44. Cheng AC, Holmes M, Irving LB, Brown SG, Waterer GW, Korman TM, Friedman ND,  Senanayake S, Dwyer DE, Brady S, Simpson G, Wood-Baker R, Upham J, Paterson D, Jenkins C, Wark P, Kelly PM, Kotsimbos T. Influenza Vaccine Effectiveness against Hospitalisation with Confirmed Influenza in the 2010-11 Seasons: A Test-negative  Observational Study. PLoS One. 2013 Jul 16; 8(7):e68760.

45. Chirumbolo S. Basophil activation test to optimize the diagnosis of adverse effects following immunization to vaccines. Iran J Allergy Asthma Immunol. 2013 Jul 9; 12(3):196-202.

46. Chit A, Parker J, Halperin SA, Papadimitropoulos M, Krahn M, Grootendorst P.  Toward more specific and transparent research and development costs: The case of  seasonal influenza vaccines. Vaccine. 2013 Jul 3. [Epub ahead of print].

47. Choi UY, Lee SY, Ma SH, Jang YT, Kim JY, Kim HM, Kim JH, Kim DS, Kim YS, Kang JH. Epidemiological changes in rotavirus gastroenteritis in children under 5 years of age after the introduction of rotavirus vaccines in Korea. Eur J Pediatr. 2013 Jul; 172(7):947-52.

48. Choi WS. Herpes zoster vaccine in Korea. Clin Exp Vaccine Res. 2013 Jul;2(2):92-6.

49. Christian LM, Porter K, Karlsson E, Schultz-Cherry S, Iams JD. Serum proinflammatory cytokine responses to influenza virus vaccine among women during  pregnancy versus non-pregnancy. Am J Reprod Immunol. 2013 Jul; 70(1):45-53.

50. Clark A, Jauregui B, Griffiths U, Janusz CB, Bolaños-Sierra B, Hajjeh R, Andrus JK, Sanderson C. TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination. Vaccine. 2013 Jul 2;31 Suppl 3:C19-29.

51. Clark AD, Griffiths UK, Abbas SS, Rao KD, Privor-Dumm L, Hajjeh R, Johnson H, Sanderson C, Santosham M. Impact and Cost-Effectiveness of Haemophilus influenzae Type b Conjugate Vaccination in India. J Pediatr. 2013 Jul;163(1 Suppl):S60-72.

52. Clay PG. Treatments for cystic fibrosis, increasing solubility and bioavailability, and influenza vaccination dosage. J Am Pharm Assoc (2003). 2013 Jul 1; 53(4):448.

53. Clegg CH, Rininger JA, Baldwin SL. Clinical vaccine development for H5N1 influenza. Expert Rev Vaccines. 2013 Jul; 12(7):767-77.

54. Cohn AC, Harrison LH. Meningococcal vaccines: current issues and future strategies. Drugs. 2013 Jul; 73(11):1147-55.

55. Cook MC, Gibeault S, Filippenko V, Ye Q, Wang J, Kunkel JP. Serogroup quantitation of multivalent polysaccharide and polysaccharide-conjugate meningococcal vaccines from China. Biologicals. 2013 Jul; 41(4):261-8.

56. Cortese MM, Immergluck LC, Held M, Jain S, Chan T, Grizas AP, Khizer S, Barrett C, Quaye O, Mijatovic-Rustempasic S, Gautam R, Bowen MD, Moore J, Tate JE, Parashar UD, Vázquez M. Effectiveness of monovalent and pentavalent rotavirus vaccine. Pediatrics. 2013 Jul; 132(1):e25-33.

57. Coulibaly D, Nzussouo NT, Kadjo HA, Traoré Y, Ekra DK, Chérif D, Kouassi PD,  N'gattia AK, Dagnan SN. Pandemic Influenza A(H1N1) in Cote d'Ivoire: health-care  providers' knowledge of influenza and attitudes towards vaccination. J Infect Dev Ctries. 2013 Jul 15; 7(7):499-506.

58. Crowcroft NS, McKenzie KJ. Inoculating communities against vaccine scare stories. Lancet Infect Dis. 2013 Jul; 13(7):564-5.

59. Darrieux M, Goulart C, Briles D, Leite LC. Current status and perspectives on protein-based pneumococcal vaccines. Crit Rev Microbiol. 2013 Jul 29. [Epub ahead of print].

60. Darveau RP, Chilton PM. Naturally occurring low biological reactivity lipopolysaccharides as vaccine adjuvants. Expert Rev Vaccines. 2013 Jul; 12(7):707-9.

61. David R. Viral infection: Propelling vaccinia virus to the neighbours. Nat Rev Microbiol. 2013 Jul 22. [Epub ahead of print].

62. De Groot AS, Einck L, Moise L, Chambers M, Ballantyne J, Malone RW, Ardito M, Martin W. Making vaccines "on demand": A potential solution for emerging pathogens and biodefense? Hum Vaccin Immunother. 2013 Jul 22; 9(9). [Epub ahead of print].

63. de Hon F, Poland GA. Submission of articles to Vaccine: A fast and fair peer  review process. Vaccine. 2013 Jul 11; 31(32):3207-8.

64. De la Hoz-Restrepo F, Castañeda-Orjuela C, Paternina A, Alvis-Guzman N. Systematic review of incremental non-vaccine cost estimates used in cost-effectiveness analysis on the introduction of rotavirus and pneumococcal vaccines. Vaccine. 2013 Jul 2; 31 Suppl 3:C80-7.

 65. De Oliveira LH, Giglio N, Ciapponi A, Martí SG, Kuperman M, Sanwogou NJ, Ruiz-Matus C, Marinho de Sousa MF. Temporal trends in diarrhea-related hospitalizations and deaths in children under age 5 before and after the introduction of the rotavirus vaccine in four Latin American countries. Vaccine.  2013 Jul 2; 31 Suppl 3:C99-C108.

66. de Oliveira LH, Toscano CM, Sanwogou NJ, Ruiz-Matus C, Tambini G, Roses-Periago M, Andrus JK. Systematic documentation of new vaccine introduction  in selected countries of the Latin American Region. Vaccine. 2013 Jul 2; 31 Suppl 3:C114-22.

67. de Quadros C. Historical perspectives on new vaccine introduction in Latin America and the Caribbean. Vaccine. 2013 Jul 2; 31 Suppl 3:C4-5.

68. de Whalley PC, Snape MD, Plested E, Thompson B, Nuthall E, Omar O, Borrow R,  Pollard AJ. Long-term seroprotection after an adolescent booster meningococcal serogroup C vaccination. Arch Dis Child. 2013 Jul 13. [Epub ahead of print].

69. Deal C, Pekosz A, Ketner G. Prospects for oral replicating adenovirus-vectored vaccines. Vaccine. 2013 Jul 11; 31(32):3236-43.

70. Demuth PC, Min Y, Irvine DJ, Hammond PT. Implantable Silk Composite Microneedles for Programmable Vaccine Release Kinetics and Enhanced Immunogenicity in Transcutaneous Immunization. Adv Healthc Mater. 2013 Jul 12. [Epub ahead of print].

71. Dolin R. The quadrivalent approach to influenza vaccination. J Infect Dis. 2013 Aug;208(4):539-40.

72. Donald RG, Flint M, Kalyan N, Johnson E, Witko SE, Kotash C, Zhao P, Megati S, Yurgelonis I, Lee PK, Matsuka YV, Severina E, Deatly A, Sidhu M, Jansen KU, Minton NP, Anderson AS. A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile. Microbiology. 2013 Jul;159(Pt 7):1254-66.

73. Donnan EJ, Fielding JE, Rowe SL, Franklin LJ, Vally H. A cross sectional survey of attitudes, awareness and uptake of the parental pertussis booster vaccine as part of a cocooning strategy, Victoria, Australia. BMC Public Health.  2013 Jul 23; 13:676.

74. Drysdale SB. Narcolepsy risk after A/H1N1 2009 influenza vaccination. Thorax. 2013 Jul 29. [Epub ahead of print].

75. Du L, Zhao G, Kou Z, Ma C, Sun S, Poon VK, Lu L, Wang L, Debnath AK, Zheng BJ, Zhou Y, Jiang S. Identification of Receptor-Binding Domain in S protein of the Novel Human Coronavirus MERS-CoV as an Essential Target for Vaccine Development. J Virol. 2013 Jul 3. [Epub ahead of print].

76. Dumortier B, Nosbaum A, Ponvert C, Nicolas JF, Bérard F. [Measles-Mumps-Rubella vaccination of an egg-allergic child sensitized to gelatin]. Arch Pediatr. 2013 Aug; 20(8):867-70.

77. Durbin A, Whitehead SS. Response to "Analyzing the development of vaccines for flavivirus-endemic scenarios: the case of dengue in Peru". J Infect Dis. 2013 Jul 11. [Epub ahead of print].

78. Dutta AK. Immunization in Practice - Clearing the Cobwebs: Author's Reply. Indian J Pediatr. 2013 Jul 17. [Epub ahead of print].

79. Eastwood K, Durrheim D, Cashman P. Availability of the northern hemisphere influenza vaccine for Australians travelling overseas. J Clin Virol. 2013 Jul; 57(3):270.

80. Eckerle I, Keller-Stanislawski B, Santibanez S, Buderus S, Hillmann M, Drosten C, Eis-Hübinger AM. Nonfebrile seizures after mumps, measles, rubella, and varicella-zoster virus combination vaccination with detection of measles virus RNA in serum, throat, and urine. Clin Vaccine Immunol. 2013 Jul; 20(7):1094-6.

81. Edens C, Collins ML, Ayers J, Rota PA, Prausnitz MR. Measles vaccination using a microneedle patch. Vaccine. 2013 Jul 25; 31(34):3403-9.

82. Ekström N, Ahman H, Palmu A, Grönholm S, Kilpi T, Käyhty H; FinOM Study Group. Concentration and high avidity of pneumococcal antibodies persist at least 4 years after immunization with pneumococcal conjugate vaccine in infancy. Clin Vaccine Immunol. 2013 Jul; 20(7):1034-40.

83. Elkin Z, Cohen EJ, Goldberg JD, Gillespie C, Li X, Jung J, Cohen M, Park L, Perskin MH. Studying physician knowledge, attitudes, and practices regarding the  herpes zoster vaccine to address perceived barriers to vaccination. Cornea. 2013 Jul; 32(7):976-81.

84. Esposito S, Zampiero A, Terranova L, Montinaro V, Scala A, Ansuini V, Principi N. Genetic characteristics of Neisseria meningitidis serogroup B strains carried by adolescents living in Milan, Italy: Omplications for vaccine efficacy. Hum Vaccin Immunother. 2013 Jul 23; 9(11). [Epub ahead of print].

85. Eypper EH, Johnson PV, Purro EI, Hohmann EL. Transcutaneous immunization of healthy volunteers with an attenuated Listeria monocytogenes vaccine strain and cholera toxin adjuvant. Vaccine. 2013 Jul 11; 31(32):3257-61.

86. Ferdinands JM, Gargiullo P, Haber M, Moore M, Belongia EA, Shay DK. Inactivated influenza vaccines for prevention of community-acquired pneumonia: the limits of using nonspecific outcomes in vaccine effectiveness studies. Epidemiology. 2013 Jul; 24(4):530-7.

87. Foster SL, Short CT, Angelo LB. Vaccination of patients with altered immunocompetence. J Am Pharm Assoc (2003). 2013 Jul 1; 53(4):438-40.

88. Fox CB, Haensler J. An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants. Expert Rev Vaccines. 2013 Jul; 12(7):747-58.  

89. Franco LM, Bucasas KL, Wells JM, Niño D, Wang X, Zapata GE, Arden N, Renwick A, Yu P, Quarles JM, Bray MS, Couch RB, Belmont JW, Shaw CA. Integrative genomic  analysis of the human immune response to influenza vaccination. Elife. 2013 Jul 16; 2:e00299.

90. Fricke KL, Gastañaduy MM, Klos R, Bégué RE. Correlates of improved influenza vaccination of healthcare personnel: a survey of hospitals in Louisiana. Infect Control Hosp Epidemiol. 2013 Jul; 34(7):723-9.

91. Furman D, Jojic V, Kidd B, Shen-Orr S, Price J, Jarrell J, Tse T, Huang H, Lund P, Maecker HT, Utz PJ, Dekker CL, Koller D, Dis MM. Apoptosis and other immune biomarkers predict influenza vaccine responsiveness. Mol Syst Biol. 2013 Jul 2; 9:680.

92. Gans HA, Maldonado YA. Loss of passively acquired maternal antibodies in highly vaccinated populations: an emerging need to define the ontogeny of infant immune responses. J Infect Dis. 2013 Jul; 208(1):1-3.

93. Gargano LM, Herbert NL, Painter JE, Sales JM, Morfaw C, Rask K, Murray D, Diclemente RJ, Hughes JM. Impact of a physician recommendation and parental immunization attitudes on receipt or intention to receive adolescent vaccines. Hum Vaccin Immunother. 2013 Jul 24; 9(12). [Epub ahead of print].

94. Gessner BD, Brooks WA, Neuzil KM, Vernet G, Bright RA, Tam JS, Bresee J, Monto AS. Vaccines as a tool to estimate the burden of severe influenza in children of low-resourced areas (November 30-December 1, 2012, Les Pensieres, Veyrier-du-Lac, France). Vaccine. 2013 Jul 11;31(32):3222-8.

95. Getie-Kebtie M, Sultana I, Eichelberger M, Alterman M. Label-free mass spectrometry-based quantification of hemagglutinin and neuraminidase in influenza virus preparations and vaccines. Influenza Other Respi Viruses. 2013 Jul; 7(4):521-30.

96. Ghanem S, Hassan S, Saad R, Dbaibo GS. Quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine (MenACWY-TT): a review. Expert Opin Biol Ther. 2013 Aug; 13(8):1197-205.

 97. Giannakopoulos P, Chrysovergis A, Xirogianni A, Nikolopoulos TP, Radiotis A, Lebessi E, Tsakanikos M, Tzanakaki G, Tsolia MN. Microbiology of Acute Mastoiditis and Complicated or Refractory Acute Otitis Media among Hospitalized Children in the Post Vaccination Era. Pediatr Infect Dis J. 2013 Jul 26. [Epub ahead of print].

98. Giri P, Basu S, Farrow D, Adisesh A. Cost-effectiveness analysis of MMR immunization in health care workers. Occup Med (Lond). 2013 Jul 16. [Epub ahead of print].

99. Glassman A. Beyond methods and studies: Building institutions for better public spending on vaccination. Vaccine. 2013 Jul 2; 31 Suppl 3:C10-1.

100. Goldstone SE, Jessen H, Palefsky JM, Giuliano AR, Moreira ED Jr, Vardas E, Aranda C, Hillman RJ, Ferris DG, Coutlee F, Marshall JB, Vuocolo S, Haupt RM, Guris D, Garner E. Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males. Vaccine. 2013 Jul 2. [Epub ahead of print].

101. Grabiel M, Reutzel TJ, Wang S, Rubin R, Leung V, Ordonez A, Wong M, Jordan E. HPV and HPV Vaccines: The Knowledge Levels, Opinions, and Behavior of Parents. J Community Health. 2013 Jul 12. [Epub ahead of print].

102. Greenhawt MJ. Establishing the safety of influenza vaccine in egg-allergic individuals. Pediatr Ann. 2013 Jul 1; 42(7):122-7.

103. Griffin MR, Zhu Y, Moore MR, Whitney CG, Grijalva CG. U.S. hospitalizations  for pneumonia after a decade of pneumococcal vaccination. N Engl J Med. 2013 Jul 11; 369(2):155-63.

104. Griffiths UK, Clark A, Hajjeh R. Cost-Effectiveness of Haemophilus influenzae Type b Conjugate Vaccine in Low- and Middle-Income Countries: Regional Analysis and Assessment of Major Determinants. J Pediatr. 2013 Jul; 163(1 Suppl):S50-S59.e9.

105. Grund S, Pietzonka S, Michel S, Adams O. Serum antibodies against native and denaturated hemagglutinin glycoproteins detected by ELISA as correlates of protection after influenza vaccination in healthy vaccinees and in kidney transplant recipients. J Virol Methods. 2013 Jul 26. [Epub ahead of print].

106. Guglielmetti S, Fracassetti D, Taverniti V, Del Bo' C, Vendrame S, Klimis-Zacas D, Arioli S, Riso P, Porrini M. Differential modulation of human intestinal Bifidobacterium populations after consumption of a wild blueberry (Vaccinium angustifolium) drink. J Agric Food Chem. 2013 Jul 24. [Epub ahead of print].

107. Hajjeh R, Mulholland K, Schuchat A, Santosham M. Progress towards Demonstrating the Impact of Haemophilus influenzae Type b Conjugate Vaccines Globally. J Pediatr. 2013 Jul;163(1 Suppl):S1-3.

108. Halstead SB. Identifying protective dengue vaccines: Guide to mastering an empirical process. Vaccine. 2013 Jul 26. [Epub ahead of print].

109. Hanquet G, Valenciano M, Simondon F, Moren A. Vaccine effects and impact of  vaccination programmes in post-licensure studies. Vaccine. 2013 Jul 12. [Epub ahead of print].

110. Harenberg A, Begue S, Mamessier A, Gimenez-Fourage S, Ching Seah C, Wei Liang A, Li Ng J, Yun Toh X, Archuleta S, Wilder-Smith A, Shek LP, Wartel-Tram A, Bouckenooghe A, Lang J, Crevat D, Caillet C, Guy B. Persistence of Th1/Tc1 responses one year after tetravalent dengue vaccination in adults and adolescents in Singapore. Hum Vaccin Immunother. 2013 Jul 9; 9(11). [Epub ahead of print].

111. Hayford KT, Al-Emran HM, Moss WJ, Shomik MS, Bishai D, Levine OS. Validation of an anti-measles virus-specific IgG assay with oral fluid samples for immunization surveillance in Bangladesh. J Virol Methods. 2013 Jul 18. [Epub ahead of print].

112. Hechter RC, Chao C, Sy LS, Ackerson BK, Slezak JM, Sidell MA, Jacobsen SJ. Quadrivalent Human Papillomavirus Vaccine Uptake in Adolescent Boys and Maternal  Utilization of Preventive Care and History of Sexually Transmitted Infections. Am J Public Health. 2013 Jul 18. [Epub ahead of print].

113. Hemming M, Vesikari T. Genetic diversity of G1P[8] rotavirus VP7 and VP8(∗)  antigens in Finland over a 20-year period: No evidence for selection pressure by  universal mass vaccination with RotaTeq® vaccine. Infect Genet Evol. 2013 Jul 4; 19C:51-58. [Epub ahead of print].

114. Herrera D, Vásquez C, Corthésy B, Franco MA, Angel J. Rotavirus specific plasma secretory immunoglobulin in children with acute gastroenteritis and children vaccinated with an attenuated human rotavirus vaccine. Hum Vaccin Immunother. 2013 Jul 9; 9(11). [Epub ahead of print].

115. Hinman AR. Perspectives on sustainable vaccine introduction. Vaccine. 2013 Jul 2;31 Suppl 3:C8-9.

116. Hofman R, van Empelen P, Vogel I, Raat H, van Ballegooijen M, Korfage IJ. Parental Decisional Strategies Regarding HPV Vaccination Before Media Debates: A  Focus Group Study. J Health Commun. 2013 Jul; 18(7):866-80.

117. Hofstetter AM, Natarajan K, Rabinowitz D, Martinez RA, Vawdrey D, Arpadi S,  Stockwell MS. Timeliness of pediatric influenza vaccination compared with seasonal influenza activity in an urban community, 2004-2008. Am J Public Health. 2013 Jul; 103(7):e50-8.

118. Holder NA, Katzenellenbogen R, Middleman AB. Human Papillomavirus Vaccines:  Factors That Affect Vaccine Knowledge and Delivery. J Adolesc Health. 2013 Jul 3. [Epub ahead of  print].

119. Hollmeyer H, Hayden F, Mounts A, Buchholz U. Review: interventions to increase influenza vaccination among healthcare workers in hospitals. Influenza Other Respi Viruses. 2013 Jul;7(4):604-21.

120. Hu Y, Li Q, Chen E, Chen Y, Qi X. Determinants of Childhood Immunization Uptake among Socio-Economically Disadvantaged Migrants in East China. Int J Environ Res Public Health. 2013 Jul 9; 10(7):2845-56.

121. Hyde TB, Andrus JK, Dietz VJ; Integrated All-VPD Surveillance Working Group. Critical issues in implementing a national integrated all-vaccine preventable disease surveillance system. Vaccine. 2013 Jul 2; 31 Suppl 3:C94-8.

122. Hébert-Dufresne L, Allard A, Young JG, Dubé LJ. Global efficiency of local immunization on complex networks. Sci Rep. 2013 Jul 10; 3:2171.

123. Iacobucci G. Flu vaccinations for school age children in England are cost effective, say experts. BMJ. 2013 Jul 25; 347:f4749.

124. Ibrahim N, Wicklund A, Jamin A, Wiebe MS. Barrier to autointegration factor (BAF) inhibits vaccinia virus intermediate transcription in the absence of the viral B1 kinase. Virology. 2013 Jul 24. [Epub ahead of print].

125. Imdad A, Tserenpuntsag B, Blog DS, Halsey NA, Easton DE, Shaw J. Religious exemptions for immunization and risk of pertussis in new york state, 2000-2011. Pediatrics. 2013 Jul;132(1):37-43.

126. Iqbal S, Barile JP, Thompson WW, Destefano F. Number of antigens in early childhood vaccines and neuropsychological outcomes at age 7-10 years. Pharmacoepidemiol Drug Saf. 2013 Jul 12. [Epub ahead of print].

127. Iwasa T, Wada K. Reasons for and against receiving influenza vaccination in a working age population in Japan: a national cross-sectional study. BMC Public Health. 2013 Jul 12; 13(1):647. [Epub ahead of print].

128. Jackson C, Mann A, Mangtani P, Fine P. Effectiveness of Haemophilus influenzae Type b Vaccines Administered According to Various Schedules: Systematic Review and Meta-Analysis of Observational Data. Pediatr Infect Dis J.  2013 Jul 9. [Epub ahead of print].

129. Jang YH, Seong BL. Toward a universal influenza vaccine: from the perspective of protective efficacy. Clin Exp Vaccine Res. 2013 Jul; 2(2):71-3.

130. Janssen WJ, Bloem AC, Vellekoop P, Driessen GJ, Boes M, van Montfrans JM. Measurement of Pneumococcal Polysaccharide Vaccine Responses for Immunodeficiency Diagnostics: Combined IgG Responses Compared to Serotype Specific IgG Responses.  J Clin Immunol. 2013 Jul 24. [Epub ahead of print].

131. Jiang Y, Gauthier A, Postma MJ, Ribassin-Majed L, Largeron N, Bresse X. A critical review of cost-effectiveness analyses of vaccinating males against human papillomavirus. Hum Vaccin Immunother. 2013 Jul 23; 9(11). [Epub ahead of print].

132. Jorgensen P, Wasley A, Mereckiene J, Cotter S, Weber JT, Brown CS. Unequal access to vaccines in the WHO European Region during the A(H1N1) influenza pandemic in 2009. Vaccine. 2013 Jul 8. [Epub ahead of print].

133. Kairu-Wanyoike SW, Kaitibie S, Taylor NM, Gitau GK, Heffernan C, Schnier C,  Kiara H, Taracha E, McKeever D. Exploring farmer preferences for contagious bovine pleuropneumonia vaccination: a case study of Narok District of Kenya. Prev Vet Med. 2013 Jul 1; 110(3-4):356-69.

134. Karve S, Meier G, Davis KL, Misurski DA, Wang CC. Influenza-related health care utilization and productivity losses during seasons with and without a match  between the seasonal and vaccine virus B lineage. Vaccine. 2013 Jul 18; 31(33):3370-88.

135. Keating GM. Shingles (herpes zoster) vaccine (zostavax(®)): a review of its  use in the prevention of herpes zoster and postherpetic neuralgia in adults aged  ≥50 years. Drugs. 2013 Jul; 73(11):1227-44.

136. Kennedy RB, Oberg AL, Ovsyannikova IG, Haralambieva IH, Grill D, Poland GA.  Transcriptomic profiles of high and low antibody responders to smallpox vaccine.  Genes Immun. 2013 Jul;14(5):277-85.

137. Kester LM, Zimet GD, Fortenberry JD, Kahn JA, Shew ML. A national study of HPV vaccination of adolescent girls: rates, predictors, and reasons for non-vaccination. Matern Child Health J. 2013 Jul; 17(5):879-85.

138. Kharbanda EO, Parker E, Nordin JD, Hedblom B, Rolnick SJ. Receipt of human papillomavirus vaccine among privately insured adult women in a U.S. Midwestern Health Maintenance Organization. Prev Med. 2013 Jul 13. [Epub ahead of print].

139. Khodyakov D, Uscher-Pines L, Lorick SA, Lindley MC, Shier V, Harris K. A qualitative analysis of the impact of healthcare personnel influenza vaccination  requirements in California. Vaccine. 2013 Jul 8. [Epub ahead of print].

140. Kieninger D, Sheldon E, Lin WY, Yu CJ, Bayas JM, Gabor JJ, Esen M, Fernandez Roure JL, Narejos Perez S, Alvarez Sanchez C, Feng Y, Claeys C, Peeters M, Innis  BL, Jain V. Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged >=18 years. BMC Infect Dis. 2013 Jul 24; 13(1):343. [Epub ahead of print].

141. Kilgore A, Donauer S, Edwards KM, Weinberg GA, Payne DC, Szilagyi PG, Rice M, Cassedy A, Ortega-Sanchez IR, Parashar UD, Staat MA. Rotavirus-associated hospitalization and emergency department costs and rotavirus vaccine program impact. Vaccine. 2013 Jul 8. [Epub ahead of print].

142. Kim JS, Bae CW. Clinical and Experimental Vaccine Research is now registered in PubMed Central, PubMed, KoreaMed, and KoreaMed Synapse. Clin Exp Vaccine Res.  2013 Jul; 2(2):74-5.

143. Kim SH, Jung DI, Yang IY, Jang SH, Kim J, Truong TT, Pham TV, Truong NU, Lee KY, Jang YS. Application of an M-cell-targeting ligand for oral vaccination induces efficient systemic and mucosal immune responses against a viral antigen.  Int Immunol. 2013 Jul 30. [Epub ahead of print]

144. Kim SY, Cho J, Cha SH, Bae CW. Current status of production and market of human vaccine products in Korea. Clin Exp Vaccine Res. 2013 Jul; 2(2):120-7.

145. Klaiman T, Oʼconnell K, Stoto M. Local health department public vaccination clinic success during 2009 pH1N1. J Public Health Manag Pract. 2013 Jul-Aug; 19(4):E20-6.

146. Klein NP, Baine Y, Bianco V, Lestrate PR, Naz A, Blatter M, Friedland LR, Miller JM. One or two doses of quadrivalent meningococcal serogroups a, C, w-135  and y tetanus toxoid conjugate vaccine is immunogenic in 9- to 12-month-old children. Pediatr Infect Dis J. 2013 Jul; 32(7):760-7.

147. Kramer L. Experts question timing of vaccination against shingles. CMAJ. 2013 Jul 9;185(10):869.

148. Kruh-Garcia NA, Murray M, Prucha JG, Dobos KM. Antigen 85 Variation across Lineages of Mycobacterium tuberculosis-Implications for Vaccine and Biomarker Success. J Proteomics. 2013 Jul 23. [Epub ahead of print].

149. Kumar A, Singh M, Thumburu KK, Jaiswal N, Kaur H, Sharma S, Agarwal A. Hib vaccine in India: A case for universal immunization. Vaccine. 2013 Jul 3. [Epub ahead of print].

150. Kumar CM, Sharma P. Immunization in Practice - Clearing the Cobwebs: Correspondence. Indian J Pediatr. 2013 Jul 17. [Epub ahead of print].

151. Kwong JC, Campitelli MA, Gubbay JB, Peci A, Winter AL, Olsha R, Turner R, Rosella LC, Crowcroft NS. Vaccine Effectiveness Against Laboratory-Confirmed Influenza Hospitalizations Among Elderly Adults During the 2010-2011 Season. Clin Infect Dis. 2013 Jul 15. [Epub ahead of print].

152. Lamontagne DS, Thiem VD, Huong VM, Tang Y, Neuzil KM. Immunogenicity of quadrivalent HPV vaccine among girls 11 to 13 years of age vaccinated using alternative dosing schedules: results 29 to 32 months after third dose. J Infect  Dis. 2013 Jul 30. [Epub ahead of print].

153. Langley JM, Carmona Martinez A, Chatterjee A, Halperin SA, McNeil S, Reisinger KS, Aggarwal N, Huang LM, Peng CT, Garcia-Sicilia J, Salamanca de la Cueva I, Cabañas F, Treviño-Garza C, Rodríguez-Weber MA, de la O M, Chandrasekaran V, Dewé W, Liu A, Innis BL, Jain VK. Immunogenicity and Safety of  an Inactivated Quadrivalent Influenza Vaccine Candidate: A Phase III Randomized Controlled Trial in Children. J Infect Dis. 2013 Aug; 208(4):544-53.

154. Larson HJ. Negotiating vaccine acceptance in an era of reluctance. Hum Vaccin Immunother. 2013 Jul 29; 9(8). [Epub ahead of print].

155. Larson HJ, Smith DM, Paterson P, Cumming M, Eckersberger E, Freifeld CC, Ghinai I, Jarrett C, Paushter L, Brownstein JS, Madoff LC. Measuring vaccine confidence: analysis of data obtained by a media surveillance system used to analyse public concerns about vaccines. Lancet Infect Dis. 2013 Jul; 13(7):606-13.

156. Lau D, Eurich DT, Majumdar SR, Katz A, Johnson JA. Effectiveness of influenza vaccination in working-age adults with diabetes: a population-based cohort study. Thorax. 2013 Jul;68(7):658-63.

157. Leidel J, Wichmann O. [The German Standing Committee on Vaccination and its  new methodological approach]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Jul; 56(7):901-2.

158. Leslie M. Solution to vaccine mystery starts to crystallize. Science. 2013 Jul 5; 341(6141):26-7.

159. Lessler J, Metcalf CJ. Balancing evidence and uncertainty when considering rubella vaccine introduction. PLoS One. 2013 Jul 5; 8(7):e67639.

160. Lev O, Wilfond BS, McBride CM. Enhancing Children against Unhealthy Behaviors-An Ethical and Policy Assessment of Using a Nicotine Vaccine. Public Health Ethics. 2013 Jul; 6(2):197-206.

161. Li XQ, Qiu LW, Chen Y, Wen K, Cai JP, Chen J, Pan YX, Li J, Hu DM, Huang YF, Liu LD, Ding XX, Guo YH, Che XY. Dengue virus envelope domain III immunization elicits predominantly cross-reactive poorly neutralizing antibodies localized to  the AB loop: Implications for dengue vaccine design. J Gen Virol. 2013 Jul 12. [Epub ahead of print].

162. Liao Q, Wong WS, Fielding R. Comparison of Different Risk Perception Measures in Predicting Seasonal Influenza Vacination among Healthy Chinese Adults in Hong Kong: A Prospective Longitudinal Study. PLoS One. 2013 Jul 19;8(7):e68019.

163. Liao Q, Wong WS, Fielding R. How do anticipated worry and regret predict seasonal influenza vaccination uptake among Chinese adults? Vaccine. 2013 Jul 16. [Epub ahead of print].

164. Lin SC, Liu WC, Lin YF, Huang YH, Liu JH, Wu SC. Heterologous prime-boost immunization regimens using adenovirus vector and virus-like particles induce broadly neutralizing antibodies against H5N1 avian influenza viruses. Biotechnol  J. 2013 Jul 1. [Epub ahead of print].

165. Lindow JC, Durbin AP, Whitehead SS, Pierce KK, Carmolli MP, Kirkpatrick BD.  Vaccination of volunteers with low-dose, live-attenuated, dengue viruses leads to serotype-specific immunologic and virologic profiles. Vaccine. 2013 Jul 18; 31(33):3347-52.

166. Link-Gelles R, Thomas A, Lynfield R, Petit S, Schaffner W, Harrison L, Farley MM, Aragon D, Nicols M, Kirley PD, Zansky S, Jorgensen J, Juni BA, Jackson D, Moore M, Lipsitch M. Geographic and temporal trends in antimicrobial nonsusceptibility in Streptococcus pneumoniae in the post-vaccine era in the United States. J Infect Dis. 2013 Jul 12. [Epub ahead of print].

167. Liu IF, Leu HB. A rebuttal to "a new discussion for effects of annual influenza vaccination on mortality and hospitalization in elderly patients with ischemic heart disease: a nationwide population based study". Prev Med. 2013 Jul; 57(1):69.

168. Liu Y, Yin Y, Wang LY, Zhang W, Chen X, Yang X, Xu J, Ma G. Engineering biomaterial-associated complement activation to improve vaccine efficacy. Biomacromolecules. 2013 Jul 22. [Epub ahead of print].

169. Lopman B, Vicuña Y, Salazar F, Broncano N, Esona MD, Sandoval C, Gregoricus  N, Bowen MD, Payne D, Vaca M, Chico M, Parashar U, Cooper PJ. Household transmission of rotavirus in a community with rotavirus vaccination in quininde, ecuador. PLoS One. 2013 Jul 9;8(7):e67763.

170. Lottenbach KR, Kelly-Aehle SM, Brenneman KE, Curtiss R 3rd, Frey SE. Rapid,  Sensitive Recovery of Recombinant Attenuated Salmonella enterica serovar Typhi Vaccine Strains from Human Blood. Clin Vaccine Immunol. 2013 Jul 24. [Epub ahead of print].

171. Luo F, Li L, Zheng D, Zhang Z, Wang Z, Yang L, Liu Z, Ai X, Bai Y, Lu Q, Shi N. A randomized, controlled, blinded study of the safety and immunogenicity of Haemophilus influenzae type b conjugate vaccine injected at different intramuscular sites in Chinese infants. Hum Vaccin Immunother. 2013 Jul 10; 9(11). [Epub ahead of print].

172. Lupisan S, Limkittikul K, Sosa N, Chanthavanich P, Bianco V, Baine Y, Van der Wielen M, Miller JM. Meningococcal polysaccharide A O-acetylation level does  not impact the immunogenicity of the quadrivalent meningococcal tetanus toxoid conjugate vaccine (MenACWY-TT): results from a randomized, controlled Phase III study in healthy adults aged 18-25 years. Clin Vaccine Immunol. 2013 Jul 24. [Epub ahead of print].

173. Macdonald J. Tdap vaccine during pregnancy. Can Fam Physician. 2013 Jul; 59(7):726.

174. Machicado JD, Bhagya-Rao B, Davogustto G, McKelvy BJ. Acute disseminated encephalomyelitis following seasonal influenza vaccination in an elderly patient: a case report. Clin Vaccine Immunol. 2013 Jul 24. [Epub ahead of print].

175. Mahalakshmi N, Aparnaa R, Ansel Vishal L, Kaliraj P. Molecular characterization and evaluation of Onchocerca volvulus-secreted larval acidic protein 1 (SLAP1) as a putative vaccine candidate on endemic population of lymphatic filariasis. Parasitol Res. 2013 Jul 5. [Epub ahead of print].

176. Marra F, Young F, Richardson K, Marra CA. A Meta-analysis of intradermal versus intramuscular influenza vaccines: Immunogenicity and Adverse Events. Influenza Other Respi Viruses. 2013 Jul; 7(4):584-603.

177. Martin CE, Broecker F, Eller S, Oberli MA, Anish C, Pereira CL, Seeberger PH. Glycan arrays containing synthetic Clostridium difficile lipoteichoic acid oligomers as tools toward a carbohydrate vaccine. Chem Commun (Camb). 2013 Jul 16; 49(64):7159-61.

178. Maruri-Avidal L, Weisberg AS, Moss B. Association of the Vaccinia Virus A11  Protein with the Endoplasmic Reticulum and Crescent Precursors of Immature Virions. J Virol. 2013 Jul 17. [Epub ahead of print].

179. Mazzon M, Peters NE, Loenarz C, Krysztofinska EM, Ember SW, Ferguson BJ, Smith GL. A mechanism for induction of a hypoxic response by vaccinia virus. Proc Natl Acad Sci U S A. 2013 Jul 23; 110(30):12444-9.

180. McCarthy M. Uptake of human papillomavirus vaccine stalls in the US. BMJ. 2013 Jul 29; 347:f4798.

181. McCarthy NL, Weintraub E, Vellozzi C, Duffy J, Gee J, Donahue JG, Jackson ML, Lee GM, Glanz J, Baxter R, Lugg MM, Naleway A, Omer SB, Nakasato C, Vazquez-Benitez G, Destefano F. Mortality Rates and Cause-of-Death Patterns in a  Vaccinated Population. Am J Prev Med. 2013 Jul;45(1):91-7.

182. McElhaney JE, Coler RN, Baldwin SL. Immunologic correlates of protection and potential role for adjuvants to improve influenza vaccines in older adults. Expert Rev Vaccines. 2013 Jul;12(7):759-66.

183. Mehtälä J, Antonio M, Kaltoft MS, O'Brien KL, Auranen K. Competition between Streptococcus pneumoniae strains: implications for vaccine-induced replacement in colonization and disease. Epidemiology. 2013 Jul; 24(4):522-9.

184. Mena G, Llupià A, García-Basteiro AL, Sequera VG, Aldea M, Bayas JM, Trilla  A. Educating on professional habits: attitudes of medical students towards diverse strategies for promoting influenza vaccination and factors associated with the intention to get vaccinated. BMC Med Educ. 2013 Jul 18; 13(1):99. [Epub ahead of print].

185. Meng X, Wu X, Yan B, Deng J, Xiang Y. Analysis of the role of vaccinia virus h7 in virion membrane biogenesis with an h7-deletion mutant. J Virol. 2013 Jul; 87(14):8247-53.

186. Mergler MJ, Omer SB, Pan WK, Navar-Boggan AM, Orenstein W, Marcuse EK, Taylor J, Dehart MP, Carter TC, Damico A, Halsey N, Salmon DA. Association of vaccine-related attitudes and beliefs between parents and health care providers.  Vaccine. 2013 Jul 26. [Epub ahead of print].

187. Merten S, Schaetti C, Manianga C, Lapika B, Hutubessy R, Chaignat CL, Weiss  M. Sociocultural Determinants of Anticipated Vaccine Acceptance for Acute Watery  Diarrhea in Early Childhood in Katanga Province, Democratic Republic of Congo. Am J Trop Med Hyg. 2013 Jul 22. [Epub ahead of print].

188. Mialet-Marty T, Beuchée A, Ben Jmaa W, N'guyen N, Navarro X, Porée F, Nuyt AM, Pladys P. Possible Predictors of Cardiorespiratory Events after Immunization  in Preterm Neonates. Neonatology. 2013 Jul 24; 104(2):151-155. [Epub ahead of print].

189. Mitchell R, Trück J, Pollard AJ. Use of the 13-valent pneumococcal conjugate vaccine in children and adolescents aged 6 - 17 years. Expert Opin Biol Ther. 2013 Jul 29. [Epub ahead of print].

190. Moise L, Terry F, Ardito M, Tassone R, Latimer H, Boyle C, Martin WD, De Groot AS. Universal H1N1 influenza vaccine development: Identification of consensus class II hemagglutinin and neuraminidase epitopes derived from strains  circulating between 1980 and 2011. Hum Vaccin Immunother. 2013 Jul 11;9(7). [Epub ahead of print].

191. Mollica A, Stefanucci A, Costante R. Strategies for developing tuberculosis  vaccines: emerging approaches. Curr Drug Targets. 2013 Jul 2; 14(9):938-51.

192. Moraes JC, Carvalhanas T, Bricks LF. Should acellular pertussis vaccine be recommended to healthcare professionals? Cad Saude Publica. 2013 Jul; 29(7):1277-90.

193. Moser C, Müller M, Kaeser MD, Weydemann U, Amacker M. Influenza virosomes as vaccine adjuvant and carrier system. Expert Rev Vaccines. 2013 Jul; 12(7):779-91. 

194. Moss JL, Gilkey MB, Griffith T, Bowling JM, Dayton A, Grimshaw A, Quinn B, Brewer NT. Organizational correlates of adolescent immunization: Findings of a state-wide study of primary care clinics in North Carolina. Vaccine. 2013 Jul 8.  [Epub ahead of print].

195. Moulin JC, Silvano J, Barban V, Riou P, Allain C. Yellow fever vaccine: Comparison of the neurovirulence of new 17D-204 StamarilTM seed lots and RK 168-73 strain. Biologicals. 2013 Jul; 41(4):238-46.

196. Movsas TZ, Paneth N, Rumbeiha W, Zyskowski J, Gewolb IH. Effect of Routine Vaccination on Aluminum and Essential Element Levels in Preterm Infants. JAMA Pediatr. 2013 Jul 15. [Epub ahead of print].

197. Mullarkey CE, Boyd A, van Laarhoven A, Lefevre EA, Veronica Carr B, Baratelli M, Molesti E, Temperton NJ, Butter C, Charleston B, Lambe T, Gilbert SC. Improved adjuvanting of seasonal influenza vaccines: Preclinical studies of MVA-NP+M1 coadministration with inactivated influenza vaccine. Eur J Immunol. 2013 Jul; 43(7):1940-52.

198. Musto R, Siever JE, Johnston JC, Seidel J, Rose MS, McNeil DA. Social equity in Human Papillomavirus vaccination: a natural experiment in Calgary Canada. BMC  Public Health. 2013 Jul 9; 13(1):640.

199. Nazi I, Kelton JG, Larché M, Snider DP, Heddle NM, Crowther MA, Cook RJ, Tinmouth AT, Mangel J, Arnold DM. The effect of rituximab on vaccine responses in patients with immune thrombocytopenia. Blood. 2013 Jul 12. [Epub ahead of print].

200. Nelson EA, Lam HS, Choi KC, Ho WC, Fung LW, Cheng FW, Sung RY, Royals M, Chan PK. A pilot randomized study to assess immunogenicity, reactogenicity, safety and tolerability of two human papillomavirus vaccines administered intramuscularly and intradermally to females aged 18-26 years. Vaccine. 2013 Jul  25;31(34):3452-60.

201. Neves FP, Pinto TC, Corrêa MA, dos Anjos Barreto R, de Souza Gouveia Moreira L, Rodrigues HG, Cardoso CA, Barros RR, Teixeira LM. Nasopharyngeal carriage, serotype distribution and antimicrobial resistance of Streptococcus pneumonia among children from Brazil before the introduction of the 10-valent conjugate vaccine. BMC Infect Dis. 2013 Jul 13; 13:318.

202. Newcomer SR, Hambidge SJ, McClure DL, Daley MF, Klein NP, Glanz JM. Factors that may explain observed associations between trivalent influenza vaccination and gastrointestinal illness in young children. Vaccine. 2013 Jul 2. [Epub ahead of print].

203. Nguipdop-Djomo P, Mangtani P, Pedrazzoli D, Rodrigues LC, Abubakar I. Uptake of neonatal BCG vaccination in England: performance of the current policy recommendations. Thorax. 2013 Jul 13. [Epub ahead of print].

204. Njuguna H, Ahmed J, Oria PA, Arunga G, Williamson J, Kosgey A, Muthoka P, Mott JA, Breiman RF, Katz MA. Uptake and effectiveness of monovalent influenza A  (H1N1) pandemic 2009 vaccine among healthcare personnel in Kenya, 2010. Vaccine.  2013 Jul 13. [Epub ahead of print].

205. Nolan TJ, O'Connor MB, Bond U, Swan J, Phelan MJ. Vaccine history knowledge  of subcutaneous anti-TNF receiving rheumatology patients. Rheumatol Int. 2013 Jul;33(7):1907-8.

206. Noll M, Berchtold S, Lampe J, Malek NP, Bitzer M, Lauer UM. Primary resistance phenomena to oncolytic measles vaccine viruses. Int J Oncol. 2013 Jul; 43(1):103-12.

207. Nunes JK, Cárdenas V, Loucq C, Maire N, Smith T, Shaffer C, Måseide K, Brooks A. Modeling the public health impact of malaria vaccines for developers and policymakers. BMC Infect Dis. 2013 Jul 1; 13(1):295. [Epub ahead of print].

208. O'Connor D, Pollard AJ. Characterizing Vaccine Responses Using Host Genomic  and Transcriptomic Analysis. Clin Infect Dis. 2013 Jul 9. [Epub ahead of print].

209. O'Toole D, Corbett R. Letter to the Editor, regarding Bovine herpesvirus 1 abortion and vaccination. J Vet Diagn Invest. 2013 Jul;25(4):555.

210. Okada K, Miyazaki C, Kino Y, Ozaki T, Hirose M, Ueda K. Phase II and III Clinical Studies of Diphtheria-Tetanus-Acellular Pertussis Vaccine Containing Inactivated Polio Vaccine Derived from Sabin Strains (DTaP-sIPV). J Infect Dis. 2013 Jul; 208(2):275-83.

211. Olaya-Abril A, Jiménez-Munguía I, Gómez-Gascón L, Obando I, Rodríguez-Ortega MJ. Identification of Potential New Protein Vaccine Candidates through Pan-Surfomic Analysis of Pneumococcal Clinical Isolates from Adults. PLoS One. 2013 Jul 23;8(7):e70365.

212. Olson JD. Comments on "The effects of vaccination on serum hormone concentrations and conception rates in synchronized naive beef heifers". Theriogenology. 2013 Jul 1;80(1):70.

213. Oluwalana C, Howie SR, Secka O, Ideh RC, Ebruke B, Sambou S, Erskine J, Lowe Y, Corrah T, Adegbola RA. Incidence of Haemophilus influenzae Type b Disease in The Gambia 14 Years after Introduction of Routine Haemophilus influenzae Type b Conjugate Vaccine Immunization. J Pediatr. 2013 Jul; 163(1 Suppl):S4-7.

214. Ortiz J, Marín-Arroyo MR, Noriega-Domínguez MJ, Navarro M, Arozarena I. Color, Phenolics, and Antioxidant Activity of Blackberry (Rubus glaucus Benth.),  Blueberry (Vaccinium floribundum Kunth.), and Apple Wines from Ecuador. J Food Sci. 2013 Jul; 78(7):C985-93.

215. Otsuka SH, Tayal NH, Porter K, Embi PJ, Beatty SJ. Improving Herpes Zoster Vaccination Rates Through Use of a Clinical Pharmacist and a Personal Health Record. Am J Med. 2013 Jul 3. [Epub ahead of print].

216. Ovsyannikova IG, Haralambieva IH, Kennedy RB, O'Byrne MM, Pankratz VS, Poland GA. Genetic Variation in the IL18R1 and IL18 Genes is Associated with IFN-γ Elispot Response to Smallpox Vaccination - An Unexpected Relationship. J Infect Dis. 2013 Jul 30. [Epub ahead of print].

217. Ovsyannikova IG, Pankratz VS, Vierkant RA, Pajewski NM, Quinn CP, Kaslow RA, Jacobson RM, Poland GA. Human leukocyte antigens and cellular immune responses to anthrax vaccine adsorbed. Infect Immun. 2013 Jul;81(7):2584-91.

218. Owais A, Khowaja AR, Ali SA, Zaidi AK. Pakistan's expanded programme on immunization: An overview in the context of polio eradication and strategies for improving coverage. Vaccine. 2013 Jul 18; 31(33):3313-9.

219. Owen JL, Sahay B, Mohamadzadeh M. New generation of oral mucosal vaccines targeting dendritic cells. Curr Opin Chem Biol. 2013 Jul 5. [Epub ahead of print].

220. Pan Y, Rose CE, Haber M, Ma Y, Carrasco JL, Stewart B, Keitel WA, Keyserling H, Jacobson RM, Poland G, McNeil MM. Assessing Agreement of Repeated Binary Measurements with an Application to the CDC's Anthrax Vaccine Clinical Trial. Int J Biostat. 2013 Jul 27;9(1).

221. Pastor M, Pedraz JL, Esquisabel A. The state-of-the-art of approved and under-development cholera vaccines. Vaccine. 2013 Jul 8. [Epub ahead of print].

222. Patel M, Glass RI, Jiang B, Santosham M, Lopman B, Parashar U. A systematic  review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy. J Infect Dis. 2013 Jul; 208(2):284-94.:

223. Payne DC, Boom JA, Staat MA, Edwards KM, Szilagyi PG, Klein EJ, Selvarangan  R, Azimi PH, Harrison C, Moffatt M, Joh.ston SH, Sahni LC, Baker CJ, Rench MA, Donauer S, McNeal M, Chappell J, Weinberg GA, Tasslimi A, Tate JE, Wikswo M, Curns AT, Sulemana I, Mijatovic-Rustempasic S, Esona MD, Bowen MD, Gentsch JR, Parashar UD. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011. Clin Infect Dis. 2013 Jul;57(1):13-20.

224. Pellegrino P, Carnovale C, Perrone V, Antoniazzi S, Pozzi M, Clementi E, Radice S. No evidence of a link between multiple sclerosis and the vaccine against the human papillomavirus. Eur J Epidemiol. 2013 Jul 18. [Epub ahead of print].

225. Permpalung N, Wongrakpanich S, Korpaisarn S, Tanratana P, Angsanakul J. Trend of human rabies prophylaxis in developing countries: Toward optimal rabies  immunization. Vaccine. 2013 Jul 8. [Epub ahead of print].

226. Perry G. Reply: comments on "The effects of vaccination on serum hormone concentrations and conception rates in synchronized naive beef heifers". Theriogenology. 2013 Jul 1; 80(1):71.

227. Picón T, Alonso L, García Gabarrot G, Speranza N, Casas M, Arrieta F, Camou  T, Rosa R, Helena De Oliveira L, Verani JR. Effectiveness of the 7-valent pneumococcal conjugate vaccine against vaccine-type invasive disease among children in Uruguay: An evaluation using existing data. Vaccine. 2013 Jul 2; 31 Suppl 3:C109-13.

228. Pilishvili T, Chernyshova L, Bondarenko A, Lapiy F, Sychova I, Cohen A, Flannery B, Hajjeh R. Evaluation of the Effectiveness of Haemophilus influenzae Type b Conjugate Vaccine Introduction against Radiologically-Confirmed Hospitalized Pneumonia in Young Children in Ukraine. J Pediatr. 2013 Jul; 163(1 Suppl):S12-8.

229. Pittet LF, Posfay-Barbe KM. Immunization in transplantation: review of the recent literature. Curr Opin Organ Transplant. 2013 Jul 4. [Epub ahead of print].

230. Prospero E, Barbadoro P, Marigliano A, D'Errico MM. Health care workers, immunization and safety issues: Reflections from Italy. Am J Infect Control. 2013 Jul; 41(7):664.

231: Pruitt CN, Reese CS, Grossardt BR, Shire AM, Creedon DJ. Completion of the human papillomavirus vaccination series lags in somali adolescents. J Low Genit Tract Dis. 2013 Jul; 17(3):280-8.

232. Pöyhönen L, Kröger L, Gröndahl-Yli-Hannuksela K, Vuononvirta J, Huhtala H, He Q, Korppi M. Variant mbl2 genotypes producing low mbl may increase risk of bcg osteitis in vaccinated newborns. Acta Paediatr. 2013 Jul 19. [Epub ahead of print].

233. Qin L, Liang M, Evans DH. Genomic analysis of vaccinia virus strain TianTan  provides new insights into the evolution and evolutionary relationships between Orthopoxviruses. Virology. 2013 Jul 20; 442(1):59-66.

234. Ramsay ME. Measles: the legacy of low vaccine coverage. Arch Dis Child. 2013 Jul 29. [Epub ahead of print].

235. Rappuoli R. Vaccine adjuvants: the future is bright. Expert Rev Vaccines. 2013 Jul; 12(7):727-9.

236. Raucci U, Rossi R, Da Cas R, Rafaniello C, Mores N, Bersani G, Reale A, Pirozzi N, Menniti-Ippolito F, Traversa G, In Drug And Children IM. Stevens-johnson syndrome associated with drugs and vaccines in children: a case-control study. PLoS One. 2013 Jul 16;8(7):e68231.

237. Reed SG. Vaccine adjuvants. Expert Rev Vaccines. 2013 Jul; 12(7):705-6.

238. Riaño Galán I, Martínez González C, Sánchez Jacob M; Comité de Bioética de la Asociación Española de Pediatría. [Recommendations for making decisions when parents refuse to vaccinate their children: ethical analysis]. An Pediatr (Barc). 2013 Jul; 79(1):50.e1-5.

239. Richter SS, Heilmann KP, Dohrn CL, Riahi F, Diekema DJ, Doern GV. Pneumococcal Serotypes before and after Introduction of Conjugate Vaccines, United States, 1999-2011(1.). Emerg Infect Dis. 2013 Jul; 19(7):1074-83.

240. Rittle C. Promoting universal vaccination among workers. Workplace Health Saf. 2013 Jul;61(7):314-22; quiz 323.

241. Robison SG. Sick-visit immunizations and delayed well-baby visits. Pediatrics. 2013 Jul; 132(1):44-8.

242. Ruiz-Alejos A, Navarro-Huaman L, Segura ER. Analyzing the development of vaccines for flavivirus-endemic scenarios: The case of Dengue in Peru. J Infect Dis. 2013 Jul 11. [Epub ahead of print].

 243. Régnier S. Respiratory syncytial virus immunization program for the United States: Impact of performance determinants of a theoretical vaccine. Vaccine. 2013 Jul 26. [Epub ahead of print].

244. Rümke HC, Richardus JH, Rombo L, Pauksens K, Plaßmann G, Durand C, Devaster  JM, Dewé W, Oostvogels L. Selection of an adjuvant for seasonal influenza vaccine in elderly people: modelling immunogenicity from a randomized trial. BMC Infect Dis. 2013 Jul 26; 13(1):348. [Epub ahead of print].

245. Sadaf A, Richards JL, Glanz J, Salmon DA, Omer SB. A systematic review of interventions for reducing parental vaccine refusal and vaccine hesitancy. Vaccine. 2013 Jul 13. [Epub ahead of print].

246. Safi MA, Melesse DY, Gumel AB. Dynamics Analysis of a Multi-strain Cholera Model with an Imperfect Vaccine. Bull Math Biol. 2013 Jul; 75(7):1104-37.

247. Salinas-Rodríguez A, Manrique-Espinoza BS. Effect of the conditional cash transfer program Oportunidades on vaccination coverage in older Mexican people. BMC Int Health Hum Rights. 2013 Jul 8; 13:30.

248. Salmon DA, Halsey NA. Editorial commentary: guillain-barre syndrome and vaccinations. Clin Infect Dis. 2013 Jul; 57(2):205-7.

249. Salunke DB, Connelly SW, Shukla NM, Hermanson AR, Fox LM, David SA. Design and Development of Stable, Water-Soluble, Human Toll-like Receptor 2 Specific Monoacyl Lipopeptides as Candidate Vaccine Adjuvants. J Med Chem. 2013 Jul 10. [Epub ahead of print].

250. Samaan G, McPherson M, Partridge J. A Review of the Evidence to Support Influenza Vaccine Introduction in Countries and Areas of WHO's Western Pacific Region. PLoS One. 2013 Jul 16; 8(7):e70003.

251. Samad L, Cortina-Borja M, Bashir HE, Sutcliffe AG, Marven S, Cameron JC, Lynn R, Taylor B. Intussusception incidence among infants in the UK and Republic  of Ireland: A pre-rotavirus vaccine prospective surveillance study. Vaccine. 2013 Jul 17. [Epub ahead of print].

252. Santoro F, Ieva R, Ferraretti A, Carpagnano G, Pappalardo I, De Gennaro L, Di Biase M, Brunetti ND. Tako-Tsubo cardiomyopathy after influenza vaccination. Int J Cardiol. 2013 Jul 31; 167(2):e51-2.

253. Satheshkumar PS, Olano LR, Hammer CH, Zhao M, Moss B. Interactions of the vaccinia virus A19 protein. J Virol. 2013 Jul 24. [Epub ahead of print].

254. Satheshkumar PS, Weisberg AS, Moss B. Vaccinia virus A19 protein participates in the transformation of spherical immature particles to barrel shaped infectious virions. J Virol. 2013 Jul 24. [Epub ahead of print].

 255. Satman I, Akalin S, Cakir B, Altinel S, Study Group TD. The effect of physicians' awareness on influenza and pneumococcal vaccination rates and correlates of vaccination in patients with diabetes in Turkey: An epidemiological Study "diaVAX". Hum Vaccin Immunother. 2013 Jul 25; 9(12). [Epub ahead of print].

 256. Scheifele DW, McNeil SA, Ward BJ, Dionne M, Cooper C, Coleman B, Loeb M, Rubinstein E, McElhaney J, Hatchette T, Li Y, Montomoli E, Schneeberg A, Bettinger JA, Halperin SA, Research Network CI. Safety, immunogenicity, and tolerability of three influenza vaccines in older adults: Results of a randomized, controlled comparison. Hum Vaccin Immunother. 2013 Jul 9; 9(11). [Epub ahead of print].

257. Schmidt FI, Bleck CK, Reh L, Novy K, Wollscheid B, Helenius A, Stahlberg H,  Mercer J. Vaccinia Virus Entry Is Followed by Core Activation and Proteasome-Mediated Release of the Immunomodulatory Effector VH1 from Lateral Bodies. Cell Rep. 2013 Jul 24. [Epub ahead of print].

258. Schmidt FI, Kuhn P, Robinson T, Mercer J, Dittrich PS. Single-virus fusion experiments reveal proton influx into vaccinia virions and hemifusion lag times.  Biophys J. 2013 Jul 16; 105(2):420-31.

259. Scott S, Altanseseg D, Sodbayer D, Nymadawa P, Bulgan D, Mendsaikhan J, Watt JP, Slack MP, Carvalho MG, Hajjeh R, Edmond KM. Impact of Haemophilus influenzae  Type b Conjugate Vaccine in Mongolia: Prospective Population-Based Surveillance,  2002-2010. J Pediatr. 2013 Jul; 163(1 Suppl):S8-S11.

260. Sezin T, Egozi E, Hillou W, Avitan-Hersh E, Bergman R. Anti-laminin-332 mucous membrane pemphigoid developing after a diphtheria tetanus vaccination. JAMA Dermatol. 2013 Jul 1; 149(7):858-62.

261. Shah AH, Bregy A, Heros DO, Komotar RJ, Goldberg J. Dendritic Cell Vaccine for Recurrent High Grade Gliomas in Pediatric and Adult Subjects: Clinical Trial Protocol. Neurosurgery. 2013 Jul 17. [Epub ahead of print].

262. Shakib JH, Korgenski K, Sheng X, Varner MW, Pavia AT, Byington CL. Tetanus,  Diphtheria, Acellular Pertussis Vaccine during Pregnancy: Pregnancy and Infant Health Outcomes. J Pediatr. 2013 Jul 26. [Epub ahead of print].

263. Shcherbik S, Sergent SB, Davis WG, Shu B, Barnes J, Klimov A, Bousse T. Application of real time RT-PCR for the genetic homogeneity and stability tests of the seed candidates for live attenuated influenza vaccine production. J Virol  Methods. 2013 Jul 18. [Epub ahead of print].

264. Sheikh A, Iqbal B, Ehtamam A, Rahim M, Shaikh HA, Usmani HA, Nasir J, Ali S, Zaki M, Wahab TA, Wasim W, Aftab AA. Reasons for non-vaccination in pediatric patients visiting tertiary care centers in a polio-prone country. Arch Public Health. 2013 Jul 13; 71(1):19.

265. Silva CA, Aikawa NE, Bonfa E. Vaccinations in juvenile chronic inflammatory diseases: an update. Nat Rev Rheumatol. 2013 Jul 2. [Epub ahead of print].

266. Singh K, Marinelli T, Horowitz JD. Takotsubo cardiomyopathy after anti-influenza vaccination: catecholaminergic effects of immune system. Am J Emerg Med. 2013 Jul 25. [Epub ahead of print].

267. Singh K, Haney E, Olorunsaiye C. Maternal autonomy and attitudes towards gender norms: associations with childhood immunization in Nigeria. Matern Child Health J. 2013 Jul; 17(5):837-41.

268. Singh M, Das RR, Kumar L, Kumar R. Bacille Calmette-Guérin vaccination is associated with lower prevalence of allergic diseases in Indian children. Am J Rhinol Allergy. 2013 Jul; 27(4):107-12.

269. Siu JY. Barriers to receiving human papillomavirus vaccination among female  students in a university in Hong Kong. Cult Health Sex. 2013 Jul 4. [Epub ahead of print].

270. Song JY, Cheong HJ, Noh JY, Yang TU, Seo YB, Hong KW, Kim IS, Choi WS, Kim WJ. Long-term immunogenicity of the influenza vaccine at reduced intradermal and  full intramuscular doses among healthy young adults. Clin Exp Vaccine Res. 2013 Jul; 2(2):115-9. 

271. Souii A, Ben M'hadheb-Gharbi M, Gharbi J. Role of RNA Structure Motifs in IRES-Dependent Translation Initiation of the Coxsackievirus B3: New Insights for Developing Live-Attenuated Strains for Vaccines and Gene Therapy. Mol Biotechnol. 2013 Jul 24. [Epub ahead of print].

272. Starnini M, Machens A, Cattuto C, Barrat A, Pastor-Satorras R. Immunization strategies for epidemic processes in time-varying contact networks. J Theor Biol. 2013 Jul 16. [Epub ahead of print].

273. Stoecker C, Hampton LM, Link-Gelles R, Messonnier ML, Zhou F, Moore MR. Cost-Effectiveness of Using 2 vs 3 Primary Doses of 13-Valent Pneumococcal Conjugate Vaccine. Pediatrics. 2013 Jul 1. [Epub ahead of print].

274. Stone JW, Thornburg NJ, Blum DL, Kuhn SJ, Wright DW, Crowe JE Jr. Gold nanorod vaccine for respiratory syncytial virus. Nanotechnology. 2013 Jul 26; 24(29):295102.

275. Streng A, Grote V, Carr D, Hagemann C, Liese JG. Varicella routine vaccination and the effects on varicella epidemiology - results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006-2011. BMC Infect Dis. 2013 Jul 2; 13:303.

276. Su S, Saldanha R, Pemberton A, Bangar H, Kawamoto SA, Aronow B, Hassett DJ,  Lamkin TJ. Characterization of stable, constitutively expressed, chromosomal green and red fluorescent transcriptional fusions in the select agent bacterium,  Francisella tularensis Schu S4 and the surrogate type B live vaccine strain (LVS). Appl Microbiol Biotechnol. 2013 Jul 13. [Epub ahead of print].

277. Subbarao K, Matsuoka Y. The prospects and challenges of universal vaccines for influenza. Trends Microbiol. 2013 Jul;21(7):350-8.

278. Sullivan SG, Tay EL, Kelly H. Variable definitions of the influenza season and their impact on vaccine effectiveness estimates. Vaccine. 2013 Jul 9. [Epub ahead of print].

279. Suryadevara M, Bonville CA, Ferraioli F, Domachowske JB. Community-Centered  Education Improves Vaccination Rates in Children From Low-Income Households. Pediatrics. 2013 Jul 8. [Epub ahead of print].

280. Suwantika AA, Tu HA, Postma MJ. Cost-effectiveness of rotavirus immunization in Indonesia: Taking breastfeeding patterns into account. Vaccine. 2013 Jul 11; 31(32):3300-7.

281. Sykes A, Brooks T, Dusmet M, Nicholson AG, Hansell DM, Wilson R. Inhalational anthrax in a vaccinated soldier. Eur Respir J. 2013 Jul;42(1):285-7.

282. Tarrés A, Allué X. [Vaccines in history, or a history of vaccines]. An Pediatr (Barc). 2013 Jul; 79(1):1-2.

283. Tate JE, Haynes A, Payne DC, Cortese MM, Lopman BA, Patel MM, Parashar UD. Trends in national rotavirus activity before and after introduction of rotavirus  vaccine into the national immunization program in the United States, 2000 to 2012. Pediatr Infect Dis J. 2013 Jul; 32(7):741-4.

284. Thomas RE, Jefferson T, Lasserson TJ. Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions. Cochrane Database Syst Rev. 2013 Jul 22; 7:CD005187. [Epub ahead of print].

285: Thompson MG, McIntyre AF, Naleway AL, Black C, Kennedy ED, Ball S, Walker DK, Henkle EM, Gaglani MJ. Potential influence of seasonal influenza vaccination  requirement versus traditional vaccine promotion strategies on unvaccinated healthcare personnel. Vaccine. 2013 Jul 8. [Epub ahead of print].

286. Toscano CM, Vijayaraghavan M, Salazar-Bolaños HM, Bolaños-Acuña HM, Ruiz-González AI, Barrantes-Solis T, Fernández-Vargas I, Panero MS, de Oliveira LH, Hyde TB; iVPD Working Team. Cost analysis of an integrated vaccine-preventable disease surveillance system in Costa Rica. Vaccine. 2013 Jul 2; 31 Suppl 3:C88-93.

287. Toscano CM, Jauregui B, Janusz CB, Sinha A, Clark AD, Sanderson C, Resch S,  Matus CR, Andrus JK; ProVac Network of Centers of Excellence. Establishing a regional network of academic centers to support decision making for new vaccine introduction in Latin America and the Caribbean: The ProVac experience. Vaccine.  2013 Jul 2; 31 Suppl 3:C12-8.

288. Trent DW, Minor P, Jivapaisarnpong T, Shin J; WHO Working Group on the Quality, Safety and Efficacy of Japanese Encephalitis Vaccines (Live Attenuated)  for Human Use. WHO working group on the quality, safety and efficacy of Japanese  encephalitis vaccines (live attenuated) for human use, Bangkok, Thailand, 21-23 February 2012. Biologicals. 2013 Jul 24. [Epub ahead of print].

289. Tupin E. Fourth International Conference: Modern Vaccines/Adjuvants Formulation-Impact On Future Development: May 15-17 2013, CHUV, Lausanne, Switzerland. Hum Vaccin Immunother. 2013 Jul 29;9(9). [Epub ahead of print].

290. Unim B, Saulle R, Boccalini S, Taddei C, Ceccherini V, Boccia A, Bonanni P,  La Torre G. Economic evaluation of Varicella vaccination: results of a systematic review. Hum Vaccin Immunother. 2013 Jul 3; 9(9). [Epub ahead of print].

291. Valencia I. Phacilitate, Partnering for Vaccine Emerging Markets: June 10-11 2013, Berlin. Hum Vaccin Immunother. 2013 Jul 29; 9(9). [Epub ahead of print].

292. van Santen KL, Bednarczyk RA, Adjaye-Gbewonyo D, Orenstein WA, Davis R, Omer SB. Effectiveness of Pneumococcal Conjugate Vaccine in Infants by Maternal Influenza Vaccination Status. Pediatr Infect Dis J. 2013 Jul 12. [Epub ahead of print].

293. Vasilakos JP, Tomai MA. The use of Toll-like receptor 7/8 agonists as vaccine adjuvants. Expert Rev Vaccines. 2013 Jul; 12(7):809-19.

294. Verguet S, Murphy S, Anderson B, Johansson KA, Glass R, Rheingans R. Public  finance of rotavirus vaccination in India and Ethiopia: An extended cost-effectiveness analysis. Vaccine. 2013 Jul 16. [Epub ahead of print].

295. Viefhues M, Wegener S, Rischmüller A, Schleef M, Anselmetti D. Dielectrophoresis based continuous-flow nano sorter: fast quality control of gene vaccines. Lab Chip. 2013 Jul 2; 13(15):3111-8.

296. Villa M, Black S, Groth N, Rothman KJ, Apolone G, Weiss NS, Aquino I, Boldori L, Caramaschi F, Gattinoni A, Malchiodi G, Crucitti A, Della Cioppa G, Scarpini E, Mavilio D, Mannino S. Safety of MF59-Adjuvanted Influenza Vaccination in the Elderly: Results of a Comparative Study of MF59-Adjuvanted Vaccine Versus  Nonadjuvanted Influenza Vaccine in Northern Italy. Am J Epidemiol. 2013 Jul 17. [Epub ahead of print].

297. Villumsen M, Jess T, Sørup S, Ravn H, Sturegård E, Benn CS, Aaby P, Roth A.  Risk of Inflammatory Bowel Disease following Bacille Calmette-Guérin and Smallpox Vaccination: A Population-based Danish Case-Cohort Study. Inflamm Bowel Dis. 2013 Jul; 19(8):1717-24.

298. Waaijenborg S, Hahné SJ, Mollema L, Smits GP, Berbers GA, van der Klis FR, de Melker HE, Wallinga J. Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage. J Infect Dis. 2013 Jul; 208(1):10-6.

299. Walter EB, Clements DA. Pneumococcal Conjugate Vaccine: Are 3 Doses Equal to 4 Doses? Pediatrics. 2013 Jul 1. [Epub ahead of print].

 300. Weil Olivier C. Ten years of experience with the pneumococcal conjugate 7-valent vaccine in children. Med Mal Infect. 2013 Jul 8. [Epub ahead of print].

301. Weinberger DM, Givon-Lavi N, Shemer-Avni Y, Bar-Ziv J, Alonso WJ, Greenberg  D, Dagan R. Influence of pneumococcal vaccines and respiratory syncytial virus on alveolar pneumonia, Israel. Emerg Infect Dis. 2013 Jul; 19(7):1084-91.

302. Weniger BG, Glenn GM. Cutaneous vaccination: antigen delivery into or onto the skin. Vaccine. 2013 Jul 25; 31(34):3389-91.

303. Wheeler M, Buttenheim AM. Parental vaccine concerns, information source, and choice of alternative immunization schedules. Hum Vaccin Immunother. 2013 Jul 30; 9(8). [Epub ahead of print].

304. Whitney CG, Parashar UD. What do policy makers need to know? Lessons from the decision to add pneumococcal conjugate and rotavirus vaccines to the US immunization program. Vaccine. 2013 Jul 2; 31 Suppl 3:C6-7.

305. WHO Writing Group. Strengthening the influenza vaccine virus selection and development process: Outcome of the 2nd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at the Centre International de Conférences (CICG) Geneva, Switzerland, 7 to 9 December 2011. Vaccine. 2013 Jul 11; 31(32):3209-21.

306. Wong SS, Webby RJ. Traditional and new influenza vaccines. Clin Microbiol Rev. 2013 Jul; 26(3):476-92.

307. Wu S, Yang P, Li H, Ma C, Zhang Y, Wang Q. Influenza vaccination coverage rates among adults before and after the 2009 influenza pandemic and the reasons for non-vaccination in Beijing, China: a cross-sectional study. BMC Public Health. 2013 Jul 8; 13:636.

308. Wykes MN. Why haven't we made an efficacious vaccine for malaria? EMBO Rep.  2013 Jul 12. [Epub ahead of print].

309. Wyman MJ, Stabi KL. Concomitant administration of pneumococcal-23 and zoster vaccines provides adequate herpes zoster coverage. Ann Pharmacother. 2013 Jul; 47(7-8):1064-8.

310. Wyplosz B, Burdet C, François H, Durrbach A, Duclos-Vallée JC, Mamzer-Bruneel MF, Poujol P, Launay O, Samuel D, Vittecoq D, Consigny PH; for the GEVACCIM. Persistence of Yellow Fever Vaccine-Induced Antibodies After Solid Organ Transplantation. Am J Transplant. 2013 Jul 8. [Epub ahead of print].

311. Yang WH, Dionne M, Kyle M, Aggarwal N, Li P, Madariaga M, Godeaux O, Vaughn  DW. Long-term immunogenicity of an AS03-adjuvanted influenza A (H1N1)pdm09 vaccine in young and elderly adults: An observer-blind, randomized trial. Vaccine. 2013 Jul 12. [Epub ahead of print].

312. Yewdell JW. To dream the impossible dream: universal influenza vaccination.  Curr Opin Virol. 2013 Jun; 3(3):316-21.

313. Yi M, Marathe A. Policy Trap and Optimal Subsidization Policy under Limited  Supply of Vaccines. PLoS One. 2013 Jul 1; 8(7):e67249.

314. Yoon HJ, Clemons KV. Vaccines against Coccidioides. Korean J Intern Med. 2013 Jul; 28(4):403-7.

315. Yoshida LM, Nguyen HA, Watanabe K, Le MN, Nguyen AT, Vu HT, Yoshino H, Suzuki M, Takahashi K, Le T, Moriuch H, Kilgore PE, Edmond K, Mulholland K, Dang  DA, Ariyoshi K. Incidence of Radiologically-Confirmed Pneumonia and Haemophilus influenzae Type b Carriage before Haemophilus influenzae Type b Conjugate Vaccine Introduction in Central Vietnam. J Pediatr. 2013 Jul; 163(1 Suppl):S38-43.

316. Zehrung D, Jarrahian C, Wales A. Intradermal delivery for vaccine dose sparing: Overview of current issues. Vaccine. 2013 Jul 25; 31(34):3392-5.

317. Zhang C, Jin K, Xiao Y, Cheng Y, Huang Z, Wang S, Lu S. Potent monoclonal antibodies against Clostridium difficile toxin A elicited by DNA immunization. Hum Vaccin Immunother. 2013 Jul 12; 9(10). [Epub ahead of print].

318. Zhang WJ, Li F, Wang YH, Simayi D, Saimaiti A, Zou XG, Xiong CL, Gong FL, Cao YG. The case for semi-mandatory HPV vaccination in China. Nat Biotechnol. 2013 Jul 9; 31(7):590-1.